tion not only relieves jaundice and pruritus in these patients but also improves other symptoms and quality of life. The considerable improvement in appetite after stenting was of particular benefit.
Results are expressed as the median (range) for the 19 study patients. One week after stent insertion the symptom scores for both jaundice and pruritus were significantly (p<001) improved compared with before stenting. From the HAD scale two patients had a score of >8 (8 and 9) on the depression scale and this score was reduced to less than eight (7 and 4) in both patients after stent insertion. Overall, however, stenting had no significant effect on the scores for depression at any assessment. The scores for anxiety were significantly (p<003) reduced after stenting until the eight week assessment (before stent 4 (2-6), eight weeks after stent 1-5 (0-5)), but this benefit was not maintained at 12 weeks when the scores were unchanged from before stent insertion.
STANDARD ENDOSCOPIC STENTING V COMBINED PROCEDURE
Fifteen of 19 patients were stented with the endoscope (group 1). In four patients endoscopic stenting was unsuccessful and they were stented transhepatically during a combined procedure (group 2). The combined procedure is much more invasive than standard endoscopic stenting and symptom relief and quality of life may differ initially after the two procedures. In particular there may be more pain and associated depression and anxiety after the combined procedure. The change in scores before stenting and one week after stenting have been compared (Wilcoxon rank sum test) and no significant difference found between the two groups. This may be because of the small number of patients in group 2, however, only one patient in this group reported more severe pain after the combined procedure (mild before stent, moderate after stent). Two reported less pain (severe to mild) and one patient remained pain free.
Discussion
In this study stent insertion completely relieved jaundice and pruritus. Of the 16 patients who have been followed up until the time of death most required one stent and only one patient developed symptomatic duodenal obstruction because of tumour expansion (Table I) . These results are in agreement with previous studies, which have shown that most patients die with their original stent in situ and there is a low incidence of late duodenal obstruction. 9 Surprisingly most patients felt that their physical health and mood was good before stent insertion and despite progression of the underlying malignancy 50% reported good health up to the 12 week assessment. It is often stated that depression is a common symptom of pancreatic cancer, but in this study only two patients (11%) scored more than 8 on the HAD scale before stent insertion and in both of these patients they scored less than 8 at each assessment after stent insertion.
The most interesting finding from this study, however, was the considerable improvement in appetite and indigestion after stenting. Although it is not clear why stenting and relief of jaundice should improve appetite, we can propose several theories. Tumour There is no untreated control group in this study as we felt it was unethical to withhold treatment from some patients in view of the known benefits of stent insertion for relief of jaundice and pruritus. The two patients who eventually had a surgical bypass, however, were assessed after the attempt at stenting and their symptom scores had not changed.
In conclusion stent insertion not only relieves jaundice and pruritus but significantly improves the other important symptoms of cancer of the pancreas and enhances patients assessment of their quality of life. The mechanism of anorexia in these patients is not understood and further detailed studies are in progress. 
